Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Doctor analysing patient brain scan results

The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s.

Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition.

The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development.

Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together.

“This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”

To read more on this topic click here.

Acupuncture may alleviate Parkinson’s symptoms

Last Month

Next Month

Go Back

Share this story

Comments

Resources & Tools

Parkinson’s podcast: DBS – a report from the front lines

Get the low-down on new surgical and non-surgical interventions

Meet Julie Dodd, director of digital transformation at Parkinson’s UK

“I know many fantastic female leaders in the charity sector”

Dopamine agonists for Parkinson’s: a simple introduction

Find out more about the Parkinson’s medication

Improving access to Parkinson’s disease resources on Amazon’s Alexa

US non-profit Parkinson’s Foundation has announced a new partnership with Amazon’s smart speaker Alexa to help more people access resources related to Parkinson’s disease. As part of the collaboration, Alexa-enabled devices will answer questions about Parkinson’s disease in English and Spanish, citing sources from the Parkinson’s Foundation. The educational initiative is aimed at people with the condition, their care partners, family and friends and health professionals – and will help them find information on topics including Covid-19 and Parkinson’s, symptoms and early signs of the condition, and more. John L Lehr, president and CEO of the Parkinson’s Foundation, said: “We are thrilled to work with Amazon to move into this exciting world of smart speakers to help even more people gain access to the information about Parkinson’s disease they need most. Our hope is that this partnership will help us further reach and better support the Parkinson’s disease community throughout every…

Scientists at MIT uncover new clues about Parkinson’s disease

Neuroscientists at Massachusetts Institute of Technology (MIT), US, have developed new tools that could improve understanding of Parkinson’s disease. As part of a study, published in Science Advances, the tools were used on animals to investigate the relationship between two types of signals that are disrupted in Parkinson’s – dopamine signalling and beta-band oscillations (coordinated waves of electrical activity in the brain). The scientists found that while the animals performed certain tasks, beta-band oscillations increased while dopamine signalling declined in particular parts of the brain. Factors including an animal’s past experience and the reward value of a task also impacted the relationship between the two signals. Helen Schwerdt, a research scientist at MIT, said: “Considering electrical signals side by side with chemical signals is really important to understand how the brain works.” Ann Graybiel, a professor at MIT, added: “As these methods in neuroscience become more and more precise and…

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

A new database study of around 80,000 Covid-19 patients has found that those living with Parkinson’s disease have a 30% higher risk of dying from the virus than those without the condition. The study – conducted by researchers at the University of Iowa Health Care, US – identified that Covid-19 patients with Parkinson’s disease were generally older, more likely to be male and less likely to be African American. As these factors could also affect the risk of death from Covid-19, the researchers adjusted their statistical models to account for differences in sex, age and race and found a significantly higher risk of dying from Covid-19 in the group of patients with Parkinson’s disease. Lead researcher Dr Nandakumar Narayanan said: “We recognise the limitations of this study; it is retrospective data from a single database, but we are confident that these data show that Parkinson’s disease is [an] independent risk factor…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

Parkinson’s podcast: DBS – a report from the front lines

Interviews

Meet Julie Dodd, director of digital transformation at Parkinson’s UK

PD in Practice

Dopamine agonists for Parkinson’s: a simple introduction

Improving access to Parkinson’s disease resources on Amazon’s Alexa

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

{title}

Subscribe

Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Resources & Tools

Parkinson’s podcast: DBS – a report from the front lines

Interviews

Meet Julie Dodd, director of digital transformation at Parkinson’s UK

PD in Practice

Dopamine agonists for Parkinson’s: a simple introduction

Improving access to Parkinson’s disease resources on Amazon’s Alexa

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

{title}

Subscribe

Sign in